Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 018814

Expand all

HEPARIN SODIUM 10,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER (HEPARIN SODIUM)
2,000 UNITS/100ML
Marketing Status: Discontinued

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 10,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2,000 UNITS/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N018814
Product Number: 002
Approval Date: Jul 9, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

HEPARIN SODIUM 20,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER (HEPARIN SODIUM)
4,000 UNITS/100ML
Marketing Status: Discontinued

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 20,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4,000 UNITS/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N018814
Product Number: 001
Approval Date: Oct 31, 1983
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER (HEPARIN SODIUM)
5,000 UNITS/100ML
Marketing Status: Discontinued

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N018814
Product Number: 003
Approval Date: Jul 9, 1985
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER (HEPARIN SODIUM)
10,000 UNITS/100ML
Marketing Status: Discontinued

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N018814
Product Number: 004
Approval Date: Jul 2, 1987
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information